PLOD1 and polycystic ovary syndrome: Our results showed that MET treatment decreased serum insulin, testosterone, E2, and LH levels and promoted the secretion of FSH in PCOS rats, while DOP treatment showed similar effects to MET, indicating that DOP has the effect of improving endocrine disorder in PCOS rats.